|Bid||2.9560 x 260000|
|Ask||3.1030 x 260000|
|Day's range||3.0010 - 3.0010|
|52-week range||0.3252 - 3.4390|
|Beta (5Y monthly)||2.03|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||23 Apr 2020|
|1y target est||N/A|
Caesars in September had agreed to buy the gambling group for 2.9 billion pounds ($3.82 billion) to expand in the fast-growing U.S. sports-betting market, after beating out Apollo. The possibility of Apollo firming up its bid faded after Caesars made it clear it could terminate the deal, if William Hill decided to proceed with another offer from rival parties mentioned in a list set by Caesars.
Caesars Entertainment (NASDAQ: CZR) saw a 22% rebound in September, likely related both to its ESPN partnership and its announced acquisition plans for English sportsbook company William Hill (LSE: WMH). While Caesars isn't faring badly in its recovery, its stock still hasn't regained the full value it had before the coronavirus struck. With the earliest possible release of COVID-19 vaccines in the U.S. still roughly two months away, according to a recent estimate from Dr. Anthony Fauci, Fools investing in consumer discretionary stocks might want to weigh several factors before buying shares of Caesars.
The company, which is set to be acquired by U.S. casino operator Caesars Entertainment, estimated that shutting 100 shops for four weeks due to further local lockdowns would reduce core earnings by around 2 million pounds ($2.60 million). The betting firm said that around 10% of its betting shops are located in regions where the local COVID-19 alert level is classified as "very high" according to the government. While net revenue was down 9% for 13 weeks ended Sept. 29, the drop was lower than the 32% fall it posted for the first-half, with growth in the United States cushioning the decline.